ABBVIE INC
ABBVIE INC
Aktie · US00287Y1091 · ABBV · A1J84E (XNYS)
Übersicht Finanzkennzahlen
189,83 USD
1,19 % 2,23 USD
NYSE (XNYS) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 20:20

Aktuelle Kurse von ABBVIE INC

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNYS: NYSE
NYSE
ABBV
USD
06.06.2025 20:20
189,83 USD
187,47 USD
+1,26 %
XETR: XETRA
XETRA
4AB.DE
EUR
06.06.2025 15:35
167,20 EUR
164,80 EUR
+1,46 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 2,00 % 1,43 % -9,93 % 8,64 % 12,01 % 102,27 %

Firmenprofil zu ABBVIE INC Aktie

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Investierte Fonds

Folgende Fonds haben in investiert: ABBVIE INC investiert:

Fonds
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in Mio
9.198,56
Anteil (%)
2,52 %
Fonds
iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist)
Vol. in Mio
2.322,89
Anteil (%)
1,89 %
Fonds
iShares MSCI World Quality Dividend UCITS ETF USD (Acc)
Vol. in Mio
801,98
Anteil (%)
1,68 %
Fonds
iShares Edge MSCI World Value Factor UCITS ETF USD (Dist)
Vol. in Mio
3.006,31
Anteil (%)
1,16 %
Fonds
iShares Dow Jones Global Titans 50 UCITS ETF (DE)
Vol. in Mio
12.810,58
Anteil (%)
1,06 %

Unternehmensdaten

Name ABBVIE INC
Firma AbbVie Inc.
Symbol ABBV
Website https://www.abbvie.com
Heimatbörse XNYS NYSE
WKN A1J84E
ISIN US00287Y1091
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - General
CEO Mr. Robert A. Michael CPA
Marktkapitalisierung 270 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 55,0 T
Adresse 1 North Waukegan Road, 60064-6400 North Chicago
IPO Datum 2016-05-17
Dividenden von 'ABBVIE INC'
Ex-Datum Dividende pro Aktie
15.04.2025 1,64 USD
15.01.2025 1,64 USD
15.10.2024 1,55 USD
15.07.2024 1,55 USD
12.04.2024 1,55 USD
12.01.2024 1,55 USD
12.10.2023 1,48 USD
13.07.2023 1,48 USD
13.04.2023 1,48 USD
12.01.2023 1,48 USD

Ticker Symbole

Name Symbol
Frankfurt 4AB.F
NYSE ABBV
XETRA 4AB.DE

Weitere Aktien

Investoren die ABBVIE INC die halten, haben auch folgende Aktien im Depot:
3M CO
3M CO Aktie
ALLIANZ AG
ALLIANZ AG Aktie
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Aktie
AMAZON.CO INC
AMAZON.CO INC Aktie
APPLE INC
APPLE INC Aktie
CHARES DIG.SEC.
CHARES DIG.SEC. ETN
COCA-COLA CO
COCA-COLA CO Aktie
JOHNSON & JOHNSON
JOHNSON & JOHNSON Aktie
LLOYDS BANK 23/26 MTN
LLOYDS BANK 23/26 MTN Anleihe
META PLATFORMS INC
META PLATFORMS INC Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
NVIDIA CORP
NVIDIA CORP Aktie
ORTHO CLINICAL DIAGNOSTICS PLC
ORTHO CLINICAL DIAGNOSTICS PLC Aktie
WI.ENTRMEREAME I SYS.HDGD
WI.ENTRMEREAME I SYS.HDGD ETF
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025